The only LIMS platform fully developed on FAIR data principles launches at Bio-IT World 2023
May 25, 2023
The Labbit LIMS platform delivers FAIR-compliant, truly interoperable data from day one, driving operational efficiencies, improved cross-collaboration, and quicker, better-informed decision making Boston, MA – In response to the data management needs of laboratories worldwide, Labbit emerges as a game-changer in the industry. Unlike any other LIMS platforms available, Labbit has been built as FAIR [...]
Xylem Completes Acquisition of Evoqua
May 25, 2023
Creates World’s Most Advanced Platform to Address Critical Water Challenges Extends Xylem’s Leadership in Water Technologies, Solutions and Services, with Strong Position in Resilient, Attractive Growth Markets WASHINGTON -- Xylem Inc. (NYSE: XYL), a leading global water technology company (“Xylem” or “the Company”), today announced it has completed its acquisition of Evoqua Water Technologies Corp. [...]
CBRE Launches Rebranding of its Laboratory Services Offering
May 25, 2023
Full Spectrum Lab Services from CBRE offers extensive capabilities across industries CBRE Group, Inc. (NYSE: CBRE) announced a new brand Full Spectrum Lab Services from CBRE. For decades, CBRE has offered lab-specific services, including laboratory design and productivity consulting, lab equipment relocation, calibration maintenance, and repair, primarily for bio-pharma clients. With the recent acquisition of Full [...]
May 25, 2023
AMSBIO has introduced a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells. Personalized treatment for cancer reached a new milestone in 2017 with the FDA approval of CAR-T cells for treatment of leukemia and lymphoma. Consequently, there is now rapid growth in research [...]
Boyd Street Ventures Invests in Exum Instruments
May 25, 2023
Instrumentation company shortens development and discovery of new materials Exum Instruments is an extremely innovative hard tech company. We're particularly excited about Massbox's potential impact in the energy tech space and on Exum's Tulsa manufacturing capacity.” — James Spann, Founder & General Partner, Boyd Street Ventures NORMAN, OK, UNITED STATES -- Boyd Street Ventures announced that it [...]
Debiopharm Partners with Genedata to Digitalize Translational Research
May 25, 2023
Pioneer in advancing tomorrow’s standard of care to cure cancer and infectious diseases, Debiopharm selects Genedata Profiler, an industry-leading digital platform for translational and reverse translational research, as the cornerstone of its research and development strategy Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Debiopharm, a [...]
The only LIMS platform fully developed on FAIR data principles launches at Bio-IT World 2023
May 25, 2023
The Labbit LIMS platform delivers FAIR-compliant, truly interoperable data from day one, driving operational efficiencies, improved cross-collaboration, and quicker, better-informed decision making Boston, MA – In response to the data management needs of laboratories worldwide, Labbit emerges as a game-changer in the industry. Unlike any other LIMS platforms available, Labbit has been built as FAIR [...]
May 25, 2023
The Verder Group is proud to announce the successful acquisition of ERWEKA, a highly regarded German company renowned for its development and manufacturing of premium tablet testing equipment. With this acquisition Verder Scientific further strengthens its position and accelerates the growth trajectory in targeted niche markets with high state of the art equipment. ERWEKA, founded [...]
May 25, 2023
ASCEND by BenchSci harnesses proprietary text and image-based machine learning models, empowering scientists to dramatically improve the speed and success of research at any stage of pre-clinical drug development TORONTO, CANADA – BenchSci, a world leader in AI solutions for preclinical life sciences research and development (R&D), today announced a $95 million (US $70 million) [...]
Illumina announces preliminary results of annual meeting
May 25, 2023
Illumina shareholders re-elect eight of nine Illumina directors SAN DIEGO -- Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that based on the preliminary results of its 2023 Annual Meeting, Illumina shareholders have voted to elect eight of nine Illumina director nominees – Francis deSouza, Robert Epstein, MD, Frances Arnold, [...]

